Abingdon Health, a York-headquartered lateral flow contract research (CRO) and contract development and manufacturing organisation (CDMO), has acquired IVDeology Holdings Limited, together with its subsidiaries, in a £700,000 deal.
IVDeology is a UK-based provider of regulatory consultancy support to an international customer base in the in vitro diagnostics sector. Co-founded by regulatory experts Stuart Angell and Nancy Consterdine, both will continue to lead IVDeology as part of the wider Abingdon Health group.
Chris Yates, CEO, said: “We’re delighted to welcome Stuart, Nancy and the rest of the IVDeology team to the Abingdon Health group. The acquisition of IVDeology is in line with Abingdon’s strategy of providing our customers with all the pieces of the jigsaw required to bring products from idea to commercial success.
“The IVDeology team will strengthen Abingdon’s existing knowledge leadership and regulatory expertise. We look forward to working with the IVDeology team and supporting existing and new customers in navigating a regulatory environment going through a period of significant change.”
Stuart Angell, Managing Director of IVDeology, said: “Nancy, the rest of the IVDeology team and I are excited to be joining the Abingdon Health Group. The in vitro diagnostics sector is undergoing a significant period of regulatory change in the UK, EU and internationally.
“By combining our collective skills, knowledge, and expertise, we can support our customers and the wider IVD industry with the comprehensive service that this opportunity provides.”
